The assumption that heart disease affects men and women identically continues to undermine cardiovascular care for half the population. This persistent medical blind spot means women receive suboptimal diagnosis and treatment based on male-derived clinical standards. A comprehensive analysis from the European Heart Journal reveals that coronary artery disease operates through fundamentally different mechanisms in women compared to men, challenging decades of one-size-fits-all cardiology. Women develop more microvascular dysfunction and endothelial impairment rather than the large vessel blockages that characterize male presentations. Paradoxically, women experience less severe myocardial oxygen deprivation despite similar degrees of coronary narrowing. This biological divergence extends beyond anatomy to include distinct risk factor profiles, with hormonal fluctuations, pregnancy complications, autoimmune conditions, and cancer treatments creating unique vulnerability patterns absent in traditional male-centered risk calculators. Current diagnostic tools demonstrate systematic bias toward male physiology, leading to systematic underdiagnosis in women who subsequently receive less guideline-recommended interventions. Women also exhibit different therapeutic responses and adverse effect profiles, particularly with preventive medications. These physiological distinctions translate into worse outcomes for women experiencing acute coronary events, especially younger patients where the gender gap proves most pronounced. This represents more than academic interest—it demands fundamental restructuring of cardiovascular risk assessment, diagnostic protocols, and therapeutic approaches. The evidence suggests that effective cardiac care requires sex-specific pathways rather than modified versions of male-centered medicine, potentially transforming outcomes for millions of women currently receiving inadequate cardiovascular protection.